Q-Med AB · Uppsala Sweden ·(Pink Sheets: QMED)(OMX Stockholm: QMED)
Company Description
View Q-Med AB Locations On A US Map
This link will open in a new window
This link will open in a new window Q-Med seeks a smooth future, but thus far it still has a few wrinkles in its plans. The company develops and manufactures the high-tech goo Restylane dermatologists inject to fill in lines and creases in facial skin. Its Durolane product, also based on its non-animal sourced hyaluronic acids, is used as an injection to treat osteoarthritis of the knee. Its products are distributed in over 70 countries, but only Restylane has received FDA approval for use in the US. The Swedish company entered the US exchanges by buying up the shell of a public company in 2008. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Q-Med AB Executives
10 executives listed for Q-Med AB's Uppsala, location.
| Title | Name & Bio | Contact |
| President and CEO | Jane Murray | Network |
| SVP and CFO | William Schmitt | Network |
| VP, Information Services | David Leeney | Network |
Competition
Competitive Landscape for Q-Med AB
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top Q-Med AB Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!